Talk:Oseltamivir
This is the talk page for discussing improvements to the Oseltamivir article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1, 2, 3Auto-archiving period: 21 days |
This level-5 vital article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: |
|||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Oseltamivir.
|
This article has been mentioned by a media organization:
|
Interesting Articles About Oseltamivir Controversy
I'll just leave these here for anyone interested in further reading on the controversy. The second source might be reasonable to add and perhaps even the first (sometimes well-sourced blog material (e.g., SBM) is used in medical articles but I think community discussion would be required before doing so. Regardless, here are the links [1] (well-done EM literature blog covering the controversial data) and [2] (Canadian Family Physician review from University of Alberta assessing the quality of evidence from various systematic reviews including funding, coverage of publication bias, etc). TylerDurden8823 (talk) 07:46, 11 February 2017 (UTC)
Inline
... query, here. SandyGeorgia (Talk) 13:31, 30 April 2018 (UTC)
Trade name
I'm not sure if Fluvir is a trade name of Oseltamivir, as it is explicitly stated that it is a brand name in its corresponding unsourced article on Wikipedia, but I haven't found any external sources that explicitly state that is is brand name. AuroraButterfly (talk) 18:38, 28 February 2019 (UTC)
Oseltamivir(TamiFlu) vs EchinaForce(R)
https://virologyj.biomedcentral.com/articles/10.1186/s12985-020-01401-2
Published: 21 September 2020
In a randomized, double-blind, multi-center, non-inferiority clinical trial Echinaforce® was demonstrated to be non-inferior to Oseltamivir in patients with influenza-LIKE illness, i.e. involvement of the lower respiratory tract (cough) and systemic symptoms (e.g. headache, myalgia, fever), and CONFIRMED influenza infection with a non-significant trend towards lower incidence of complications with Echinaforce Hot Drink® compared to Oseltamivir [17].
[17.] Raus K, Pleschka S, Klein P, Schoop R, Fisher P. Effect of an Echinacea-based hot drink versus oseltamivir in influenza treatment: a randomized, double-blind, double-dummy, multicenter, noninferiority clinical trial. Curr Ther Res Clin Exp. 2015;77:66–72.
https://www.sciencedirect.com/science/article/pii/S0011393X15000053?via%3Dihub
...
The Hot Drink version of EchinaForce is mainly water and sucrose, so maybe it's just the sucrose and drinking anything hot helps:
https://www.avogel-company.ch/de/produkte/arzneimittel/echinaforce-hot-drink.php
- B-Class vital articles
- Wikipedia level-5 vital articles
- Wikipedia vital articles in Biology and health sciences
- B-Class level-5 vital articles
- Wikipedia level-5 vital articles in Biology and health sciences
- B-Class vital articles in Biology and health sciences
- B-Class pharmacology articles
- High-importance pharmacology articles
- WikiProject Pharmacology articles
- B-Class medicine articles
- Mid-importance medicine articles
- All WikiProject Medicine articles
- Wikipedia pages referenced by the press